Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Everolimus Eluting (XIENCE-V®, XIENCE-Prime® or PROMUS® Stent) With the Biolimus A9 Eluting NOBORI® Stent in All-comers: a Randomized Open Label Study

NCT01233453 is registered in ClinicalTrials.gov with Maasstad Hospital as lead sponsor.

NCT NCT01233453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01233453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Everolimus Eluting (XIENCE-V®, XIENCE-Prime® or PROMUS® Stent) With the Biolimus A9 Eluting NOBORI® Stent in All-comers: a Randomized Open Label Study
Lead sponsor
Maasstad Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2015
Enrollment
2,700 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease